Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE CAUMARTIN OPERA : revenue, balance sheet and financial ratios

SELARL PHARMACIE CAUMARTIN OPERA is a French company founded 7 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PARIS (75009), this company of category PME shows in 2024 a net income positive of 76 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE CAUMARTIN OPERA (SIREN 844571836)
Indicator 2024 2023 2022 2021 2020
Revenue N/C N/C N/C N/C N/C
Net income 75 833 € 69 684 € 204 774 € 259 623 € 89 188 €
EBITDA N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, SELARL PHARMACIE CAUMARTIN OPERA generates positive net income of 76 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2024: 89 k€ -> 76 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

75 833 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 172%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 34%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

171.97%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

33.557%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

50.6%

Solvency indicators evolution
SELARL PHARMACIE CAUMARTIN OPERA

Sector positioning

Debt ratio
171.97 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average

In 2024, the debt ratio of SELARL PHARMACIE CAUMARTI... (171.97) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
33.56% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average +6 pts over 3 years

In 2024, the financial autonomy of SELARL PHARMACIE CAUMARTI... (33.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 136.10. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

136.104

Liquidity indicators evolution
SELARL PHARMACIE CAUMARTIN OPERA

Sector positioning

Liquidity ratio
136.1 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average -47 pts over 3 years

In 2024, the liquidity ratio of SELARL PHARMACIE CAUMARTI... (136.10) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of SELARL PHARMACIE CAUMARTIN OPERA in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELARL PHARMACIE CAUMARTIN OPERA is estimated at 1 058 684 € (range 737 251€ - 1 583 852€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
737k€ 1058k€ 1583k€
1 058 684 € Range: 737 251€ - 1 583 852€
NAF 5 année 2024

Valuation method used

Net Income Multiple
75 833 € × 14.0x = 1 058 685 €
Range: 737 251€ - 1 583 853€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE CAUMARTIN OPERA with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE CAUMARTIN OPERA

What is the revenue of SELARL PHARMACIE CAUMARTIN OPERA ?

The revenue of SELARL PHARMACIE CAUMARTIN OPERA is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE CAUMARTIN OPERA profitable?

Yes, SELARL PHARMACIE CAUMARTIN OPERA generated a net profit of 76 k€ in 2024.

Where is the headquarters of SELARL PHARMACIE CAUMARTIN OPERA ?

The headquarters of SELARL PHARMACIE CAUMARTIN OPERA is located in PARIS (75009), in the department Paris.

Where to find the tax return of SELARL PHARMACIE CAUMARTIN OPERA ?

The tax return of SELARL PHARMACIE CAUMARTIN OPERA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE CAUMARTIN OPERA operate?

SELARL PHARMACIE CAUMARTIN OPERA operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.